Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Industry / Manufacturing/  US FDA bans Emcure Pharma’s India plant over manufacturing issues
BackBack

US FDA bans Emcure Pharma’s India plant over manufacturing issues

Imports from Emcure's Hinjewadi plant in Maharashtra barred, after an inspection revealed company was not meeting manufacturing standards

Emcure Pharmaceuticals has nine manufacturing plants, including one in the United States, and exports to a number of countries including the US, Europe, Brazil and Japan, according to its website. Premium
Emcure Pharmaceuticals has nine manufacturing plants, including one in the United States, and exports to a number of countries including the US, Europe, Brazil and Japan, according to its website.

Mumbai: The US Food and Drug Administration has banned drug imports from an India manufacturing unit of Emcure Pharmaceuticals Ltd over violations of standard manufacturing practices, the latest in a series of Indian firms to face such action.

In an ‘import alert’ posted on its website on Monday, the FDA said it had barred imports from Emcure’s Hinjewadi manufacturing plant in Maharashtra, after an inspection revealed the company was not meeting manufacturing quality standards.

The company has nine manufacturing plants, including one in the United States, and exports to a number of countries including the US, Europe, Brazil and Japan, according to its website.

Emcure, one of India’s top 20 drugmakers, is the latest among some of India’s largest drugmakers to have come under fire for similar violations in the last few years, hurting the country’s reputation as a reliable supplier of cheap generic drugs to the world, and impacting the growth of the $15 billion industry.

An Emcure Pharma spokesman did not immediately respond to a request for comment.

Emcure, which is a marketing partner to large multinational drugmakers such as Pfizer Inc, Roche, Novartis and Sanofi, makes drugs that are mainly used in cardiology, gynecology and to treat infections. Reuters

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Industry News, Banking News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 14 Jul 2015, 07:55 PM IST
Next Story footLogo
Recommended For You
Manufacturing Stocks
₹557.550.52%
ITC
₹4280.13%
₹2,987.85-0.37%
₹152.852%
Switch to the Mint app for fast and personalized news - Get App